Avery C. Rossidis

Avery C. Rossidis

Auto-generated profile, based on publicly available information

Avery C. Rossidis

The Children's Hospital of Philadelphia Research Institute and the Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Abramson Research Center, Philadelphia, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2019 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
DADeepthi Alapati
Deepthi Alapati
WZWilliam J. Zacharias
William J. Zacharias
HHHeather A. Hartman
Heather A. Hartman
ARAvery C. Rossidis
Avery C. Rossidis
JSJohn D. Stratigis
John D. Stratigis
WPWilliam H. Peranteau
William H. Peranteau
Monogenic lung diseases that are caused by mutations in surfactant genes of the pulmonary epithelium are marked by perinatal lethal respiratory failure or chronic diffuse parenchymal lung disease with few therapeutic options. Using a CRISPR fluorescent reporter system, we demonstrate that precisely timed in utero intra-amniotic delivery of CRISPR-Cas9 gene editing reagents during fetal development results in targeted and specific gene editing in fetal lungs. Pulmonary epithelial cells are predominantly targeted in this approach, with alveolar type 1, alveolar type 2, and airway secretory cells exhibiting high and persistent gene editing. We then used this in utero technique to evaluate a therapeutic approach to reduce the severity of the lethal interstitial lung disease observed in a mouse model of the human SFTPCI73T mutation. Embryonic expression of SftpcI73T alleles is characterized by severe diffuse parenchymal lung damage and rapid demise of mutant mice at birth. After in utero CRISPR-Cas9–mediated inactivation of the mutant SftpcI73T gene, fetuses and postnatal mice showed improved lung morphology and increased survival. These proof-of-concept studies demonstrate that in utero gene editing is a promising approach for treatment and rescue of monogenic lung diseases that are lethal at birth.

1 March 2020 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PMPatrick McGovern
Patrick McGovern
KLKendall Lawrence
Kendall Lawrence
HBHeron Baumgarten
Heron Baumgarten
ARAvery C. Rossidis
Avery C. Rossidis
AMAli Y. Mejaddam
Ali Y. Mejaddam
JGJames W. Gaynor
James W. Gaynor

1 January 2020 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
HBHeron D. Baumgarten
Heron D. Baumgarten
CWChristina M. Wright
Christina M. Wright
ARAvery C. Rossidis
Avery C. Rossidis
KLKendall M. Lawrence
Kendall M. Lawrence
AKAimee G. Kim
Aimee G. Kim
AFAlan W. Flake
Alan W. Flake
The Extra-Uterine Environment for Neonatal Development (EXTEND) aims to avoid the complications of prematurity, such as NEC. Our goal was to determine if bowel development occurs normally in EXTEND-supported lambs, with specific emphasis on markers of immaturity associated with NEC. We compared terminal ileum from 17 pre-term lambs supported on EXTEND for 2- 4 weeks to bowel from age-matched fetal lambs that developed in utero. We evaluated morphology, markers of epithelial integrity and maturation, enteric nervous system structure, and bowel motility. EXTEND-supported lamb ileum had normal villus height, crypt depth, density of mucin-containing goblet cells, and enteric neuron density. Expression patterns for I-FABP, activated caspase-3 and EGFR were normal in bowel epithelium. Transmural resistance assessed in Ussing chambers was normal. Bowel motility was also normal as assessed by ex vivo organ bath and video imaging. However, Peyer's patch organization did not occur normally in EXTEND ileum, resulting in fewer circulating B cells in experimental animals. EXTEND supports normal ileal epithelial and enteric nervous system maturation in pre-term lambs. The classic morphologic changes and cellular expression profiles associated with NEC are not seen. However, immune development within the EXTEND supported lamb bowel does not progress normally.

28 June 2018 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
ARAvery C. Rossidis
Avery C. Rossidis
HBHeron D. Baumgarten
Heron D. Baumgarten
KLKendall M. Lawrence
Kendall M. Lawrence
PMPatrick E. McGovern
Patrick E. McGovern
AMAli Y. Mejaddam
Ali Y. Mejaddam
AFAlan W. Flake
Alan W. Flake
Introduction: We have recently developed an extra-uterine environment for neonatal development (EXTEND) capable of supporting premature fetal lambs and have been able to replicate hypoxic in utero conditions by controlling fetal oxygen delivery. In this study, we investigated the fetal mitochondrial response to hypoxia. Methods: Eight premature fetal lambs were delivered via hysterotomy and transitioned to extra-uterine support for 3 weeks. The lambs were divided into 2 groups: normoxic fetuses which maintained physiologic oxygen delivery and hypoxic fetuses in which oxygen delivery was significantly reduced. Control fetuses were delivered via hysterotomy but not cannulated. Measurements of mitochondrial membrane potential (MMP) were performed in peripheral blood mononuclear cells. Results: There were no significant differences in MMP between normoxic EXTEND fetuses and controls. Hypoxic fetuses had significantly more depolarized mitochondria compared to normoxic fetuses overall, and these changes were specifically appreciated in weeks 1 and 2, but not by week 3. Hypoxic fetuses had significantly elevated levels of HIF-1α compared to normoxic fetuses in the first 2 weeks. Discussion: Normoxic fetal lambs supported by EXTEND demonstrate normal mitochondrial function as evidenced by equivalent membrane potentials compared to control fetuses. Hypoxic fetuses exhibit mitochondrial dysfunction, though they do show evidence of adaptation after 3 weeks of hypoxic exposure.

31 January 2019 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
AMAli Y. Mejaddam
Ali Y. Mejaddam
MHMatthew A. Hornick
Matthew A. Hornick
PMPatrick E. McGovern
Patrick E. McGovern
HBHeron D. Baumgarten
Heron D. Baumgarten
KLKendall M. Lawrence
Kendall M. Lawrence
AFAlan W. Flake
Alan W. Flake
Background: We recently developed an EXTrauterine Environment for Neonatal Development (EXTEND) that provides physiologic support for premature lambs. Here, we assess the efficacy of exogenous erythropoietin (EPO) to prevent anemia and transfusions on EXTEND. Materials and Methods: Lambs were cannulated at 0.7 gestation and supported on EXTEND for up to 4 weeks. The lambs were divided into three groups: (1) No EPO, (2) Low EPO (300 U kg–1 per day), and (3) High EPO (800 U kg–1 per day). Daily hematocrit and weekly complete blood count were assessed. Results: The mean percentage change in hematocrit from baseline was significantly different between the groups (No EPO –23.6 ± 7.8% vs. Low EPO –16.6 ± 6.4% vs. High EPO +2.6 ± 6.6%; p = 0.02). This occurred despite a greater median number of blood transfusions in the No EPO group (5 vs. 1 vs. 0; p = 0.02). EPO administration was associated with a higher mean corpuscular volume (MCV; p < 0.01) and reticulocyte count (p = 0.02). The High EPO group was comparable to in utero control fetuses with respect to hematocrit (p = 0.49), MCV (p = 0.24), and reticulocyte count (p = 0.68). Conclusions: EPO (800 U kg–1 per day) prevents anemia, eliminates transfusions, and restores normal red blood cell indices in premature lambs supported by EXTEND.

12 March 2019 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
ARAvery C. Rossidis
Avery C. Rossidis
AAAlessia Angelin
Alessia Angelin
KLKendall M. Lawrence
Kendall M. Lawrence
HBHeron D. Baumgarten
Heron D. Baumgarten
AKAimee G. Kim
Aimee G. Kim
AFAlan W. Flake
Alan W. Flake
Background: In an effort to mitigate the major morbidities and mortality associated with extreme prematurity, we have developed an EXTrauterine Environment for Neonatal Development (EXTEND) designed to provide physiologic support of extremely premature infants. Objectives: We have previously shown that long-term, physiologic support of premature fetal lambs is possible with EXTEND, but in this study, we sought to demonstrate bioenergetic equipoise at the tissue level. Methods: Four premature fetal lambs were delivered by hysterotomy at gestational ages (GA) of 105–107 days (term ∼145 days), cannulated via the umbilical vessels, and transitioned to support on EXTEND for 3–4 weeks. Five control fetuses were age-matched to the GA of experimental fetuses at the time of study end (128–134 days GA) and immediately sacrificed after hysterotomy. Mitochondria were isolated from the heart, liver, kidney, and skeletal muscle of fetuses at the time of sacrifice, and oxygen consumption rates (OCRs) were measured. Results: There were no differences in basal mitochondrial OCR between EXTEND and control fetuses for heart, kidney, or skeletal muscle. For liver, the basal OCR was higher in EXTEND fetuses compared to controls. There were no differences in physiologic maximal OCR or reserve capacity for any tissue analyzed. Conclusions: Fetal lambs supported by EXTEND demonstrate physiologic mitochondrial function as evidenced by adequate basal and physiologic maximal cellular respiration as well as preserved reserve capacity.